{"id":3509,"date":"2021-04-16T17:15:00","date_gmt":"2021-04-16T21:15:00","guid":{"rendered":"https:\/\/bioenterprise.ca\/marret-asset-management-announces-write-up-of-private-portfolio-of-marret-high-yield-strategies-fund-and-marret-multi-strategy-income-fund\/"},"modified":"2021-04-16T17:15:00","modified_gmt":"2021-04-16T21:15:00","slug":"marret-asset-management-announces-write-up-of-private-portfolio-of-marret-high-yield-strategies-fund-and-marret-multi-strategy-income-fund","status":"publish","type":"post","link":"https:\/\/bioenterprise.ca\/marret-asset-management-announces-write-up-of-private-portfolio-of-marret-high-yield-strategies-fund-and-marret-multi-strategy-income-fund\/","title":{"rendered":"Marret Asset Management Announces Write-Up of Private Portfolio of Marret High Yield Strategies Fund and Marret Multi-Strategy Income Fund"},"content":{"rendered":"
\n

TORONTO–(BUSINESS WIRE)–Marret Asset Management Inc. (“Marret”) today announced that Marret High Yield Strategies Fund (“MHY”) (CSE: MHY.UN) and Marret Multi-Strategy Income Fund (“MMF”) (CSE: MMF.UN) will take a 8.87% write-up in the value of securities held in Cline Mining Corporation (“Cline”). Cline is the main asset of MHY and MMF. As a result of the write-up, the net asset value per unit of MHY on April 16th will increase from $0.43 to $0.47 or by $0.04 per unit, the net asset value per class A unit of MMF on April 16th will increase from $0.21 to $0.22 or by $0.01 per class A unit, and the net asset value per class F unit of MMF on April 16th will increase from $0.22 to $0.24 or by $0.02 per class F unit.\n<\/p>\n

\nThe write-up reflects the appreciation of the shares of Allegiance Coal Limited (“Allegiance”) owned by Cline as the result of the sale of all the shares in New Elk Coal Company, LLC (“NECC”). It also reflects the progress made by Allegiance in raising capital and restarting NECC\u2019s metallurgical coal mine near Trinidad, Colorado. Allegiance now plans NECC production to commence in the last week of April and shipments to be delivered in June. Marret will continue to try and optimize the Cline asset for the benefit of the unitholders of MHY and MMF and will report on any further material developments.\n<\/p>\n

\nAbout Allegiance <\/b>\n<\/p>\n

\nAllegiance is a publicly listed (ASX:AHQ) Australian company advancing a metallurgical coal mine into production in British Columbia, Canada and the NECC mine in Colorado, USA.\n<\/p>\n

\nAbout Marret Asset Management <\/b>\n<\/p>\n

\nMarret Asset Management Inc. is a specialist fixed-income manager. With mandates in investment grade credit, short-term cash alternatives, high yield and opportunistic distressed securities, Marret\u2019s focus is on achieving positive absolute returns with emphasis on risk management. CI Financial Corp. (TSX: CIX, NYSE: CIXX) has a 65% ownership stake in Marret.\n<\/p>\n

\nForward-looking information <\/b>\n<\/p>\n

\nThis press release contains forward-looking statements and information within the meaning of applicable securities legislation. Forward-looking statements can be identified by the expressions \u201cseeks\u201d, \u201cexpects\u201d, \u201cbelieves\u201d, \u201cestimates\u201d, \u201cwill\u201d, \u201ctarget\u201d and similar expressions. The forward-looking statements are not historical facts but reflect the current expectations of Marret and the managers of the underlying portfolios regarding future results or events and are based on information currently available to them. Certain material factors and assumptions were applied in providing these forward-looking statements. All forward-looking statements in this press release are qualified by these cautionary statements. Marret believes that the expectations reflected in forward-looking statements are based upon reasonable assumptions; however, Marret can give no assurance that the actual results or developments will be realized. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations, including the matters discussed under \u201cRisks Factors\u201d in the annual information forms of MHY and MMF dated March 26, 2021. Readers, therefore, should not place undue reliance on any such forward-looking statements. Further, a forward-looking statement speaks only as of the date on which such statement is made. Marret undertakes no obligation to publicly update any such statement or to reflect new information or the occurrence of future events or circumstances except as required by securities laws. These forward-looking statements are made as of the date of this press release.<\/i>\n<\/p>\n

\"\"<\/span><\/p>\n

Contacts<\/b> <\/p>\n

\nMarret Investor Relations, 416-214-5800
\n
info@marret.com<\/a>\n<\/p>\n

\nor\n<\/p>\n

\nKathleen Cooney, CCO & COO
\n
kcooney@marret.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"TORONTO–(BUSINESS WIRE)–Marret Asset Management Inc. (“Marret”) today announced that Marret High Yield Strategies Fund (“MHY”) (CSE: MHY.UN) and Marret Multi-Strategy Income Fund (“MMF”) (CSE: MMF.UN) will take a 8.87% write-up in the value of securities held in Cline Mining Corporation (“Cline”). Cline is the main asset of MHY and MMF. As a result of the… View Article<\/a>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","footnotes":""},"categories":[22],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/bioenterprise.ca\/wp-json\/wp\/v2\/posts\/3509"}],"collection":[{"href":"https:\/\/bioenterprise.ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bioenterprise.ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bioenterprise.ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bioenterprise.ca\/wp-json\/wp\/v2\/comments?post=3509"}],"version-history":[{"count":0,"href":"https:\/\/bioenterprise.ca\/wp-json\/wp\/v2\/posts\/3509\/revisions"}],"wp:attachment":[{"href":"https:\/\/bioenterprise.ca\/wp-json\/wp\/v2\/media?parent=3509"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bioenterprise.ca\/wp-json\/wp\/v2\/categories?post=3509"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bioenterprise.ca\/wp-json\/wp\/v2\/tags?post=3509"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}